Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02735850
Brief Title: Combination of SABR and L19-IL2 in Patients With Stage IV Lung Cancer (ImmunoSABR) (ImmunoSABR)

First Submitted : March 22, 2016
First Submitted that Met QC Criteria : April 11, 2016
First Posted : April 13, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : May 22, 2017
Last Update Posted : May 23, 2017